Infliximab-associated reversible cholestatic liver disease

Mayo Clinic Proceedings

Volumn 76, Issue 1, 2001, Pages 84-86

  Menghini, Vanessa V ^a   Arora, Amindra S ^b  

^a Department of Internal Medicine ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; OBSTRUCTIVE JAUNDICE;

EID: 0035160406     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.1.84     Document Type: Article

References (10)

1. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. W Engl J Med. 1999;340:1398-1405.
2. Targan SR, Hanauer SB, van Deventer SJH, et al, Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. W Engl J Med. 1997;337:1029-1035.
3. Hanauer SB. Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther. 1999;13(suppl 4): 16-22.
4. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552-1563.
5. Knight DM, Trinh H, Le J, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol. 1993 ;30:1443-1453.
6. Remicade™ (infliximab) prescribing information [package insert]. Malvern, Pa: Centocor, Inc; August 1998.
7. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol. 1996; 271(6,ptl):G1043-G1052.
8. Lewis JH, Zimmerman HJ. Drug- and chemical-induced cholestasis. Clin Liver Dis. 1999;3:433-464.
9. Leslie KK, Reznikov L, Simon FR, Fennessey PV, Reyes H, Ribalta J. Estrogens in intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2000;95:372-376.
10. King PD, Perry MC. Hepatotoxicity of chemotherapeutic and oncologic agents. Gastroenterol Clin North Am. 1995;24:969-990.